Press Releases
PRESS RELEASE
MolecuLight Announces Presentation of its Clinical and Surgical Benefits in Reconstructive...
PRESS RELEASE
MolecuLight Secures $27.5 Million From Hayfin, a Leading Healthcare Institutional Investor
PRESS RELEASE
MolecuLight’s Pioneering Fluorescence Imaging Technology Showcased in Prestigious Burns Journal...
PRESS RELEASE
MolecuLight Featured in 11 Presentations and Posters at European Wound Management Association...
PRESS RELEASE
MolecuLight Awarded Federal Supply Contract for the US Department of Veterans Affairs
PRESS RELEASE
United States Patent and Trademark Office (USPTO) Cancels All Claims of Swift Medical’s...
PRESS RELEASE
12 Posters and Presentations Featuring MolecuLight to be Presented at the SAWC Fall 2023...
PRESS RELEASE
Latest Clinical Evidence Presented at APWCA’s Wound Week™ 2023 Illustrates the Significant...
Archive
2023
—PRESS RELEASE
Seasoned Healthcare Executive David Bassin Joins the MolecuLight Board of Directors
—PRESS RELEASELargest Published Real-World Wound Imaging Study Reports MolecuLight® led to Wound Treatment Plan Changes in up to 53% Cases
—PRESS RELEASEMolecuLight Featured in Unprecedented 24 Presentations and Posters at European Wound Management Association (EWMA) 2023 Annual Conference
—PRESS RELEASEMolecuLight Partners with WoundZoom to Deliver Cloud-Based Wound Management Solution Integrated with its Point-of-Care Bacterial Imaging
—PRESS RELEASENew Publication Reveals MolecuLight Imaging Significantly Improved Detection of Bacterial Burden Across Patients of All Skin Tones
—PRESS RELEASEMolecuLight Successfully Completes SOC 2® Type I Audit and Accreditation
—PRESS RELEASEChronic Inhibitory Bacterial Load (CIBL): New Clinical Terminology for Elevated Levels of Bacteria in Wounds that Preclude Healing
2022
—PRESS RELEASE
MolecuLight Featured in Vizient Tech Watch as Key Technology for Visualizing Bacterial Burden and Helping to Reduce Surgical Site Infections
—PRESS RELEASEMolecuLight Featured in 10 Presentations and Posters at the AAWC 2022 Annual Conference
—PRESS RELEASE2,000+ Patients’ Worth of New MolecuLight Data to be Presented at the SAWC Fall 2022 Conference
—PRESS RELEASEMolecuLight Point-of-Care Wound Imaging Devices Awarded Group Purchasing Agreement with AllSpire Health GPO
—PRESS RELEASEMolecuLight Featured in 8 Presentations and Posters at Wounds Australia 2022 Conference
—PRESS RELEASEMolecuLight Secures Financing from BDC Canada and iGan Partners to Support its Commercial Expansion
—PRESS RELEASENewly Published RCT Shows MolecuLight Fluorescence Point-of-Care Imaging Improved 12-Week Wound Healing by 204% in Diabetic Foot Ulcers
—PRESS RELEASEMolecuLightDX™ Wins Award as a Top Innovation in Wound Care 2022 From Wound Management & Prevention Journal
—PRESS RELEASEFDA 510(k) Clearance Expands Labelling of MolecuLight i:X® to Include the Ability to Identify Regions Containing Elevated Load and More Bacterial Species
—PRESS RELEASEMolecuLight Awarded Point-of-Care Wound Imaging Devices Agreement with Premier, Inc.
—PRESS RELEASEMolecuLight Added to the ISWCAP 2022 Consensus Guidelines for Optimising Prevention of Surgical Wound Complications
—PRESS RELEASEMolecuLight i:X® Receives Regulatory Clearance and Reimbursement in South Korea
—PRESS RELEASEMolecuLight Featured in Unprecedented 32 Presentations and Posters at World Union of Wound Healing Societies (WUWHS) 2022 Conference
—PRESS RELEASELatest Clinical Evidence Presented at APWCA’s Wound Week™ 2022 Illustrates the Significant Clinical Utility of the MolecuLight Point-of-Care Imaging Platform
—PRESS RELEASENew Clinical Study Finds MolecuLight i:X® Point-of-Care Imaging Improved Sensitivity of Detecting Bacterial Burden in Surgical Site Wounds by 11-Fold
—PRESS RELEASESWK Holdings Provides $10M USD to MolecuLight to Support Global Commercial Expansion
2021
—PRESS RELEASE
Latest Clinical Evidence Presented at SAWC 2021 Illustrates the Significant Clinical Utility of the MolecuLight Point-of-Care Imaging Platform
—PRESS RELEASEJoerns Healthcare Introduces Point-of-Care Imaging to Wound Care Portfolio Through MolecuLight Partnership
—PRESS RELEASELaunch of New MolecuLightDX™ Device to Enable Point-of-Care Imaging of Wounds in New Expanding Market Segments
—PRESS RELEASEStudy of 236 patients reveals utility of MolecuLight i:X® in detection and management of wound-related cellulitis
—PRESS RELEASEMolecuLight i:X® Receives FDA 510(k) Clearance for the Device’s Ability to Detect Wounds Likely to Contain Pseudomonas Aeruginosa (PA)
—PRESS RELEASEIn new publication, 96% of clinicians state that treatment plans informed using the MolecuLight procedure led to improved wound healing – MolecuLight US
—PRESS RELEASEMolecuLight Signs LMT Surgical as New Distributor for Australia and New Zealand
—PRESS RELEASENovel Technology to Help Improve Wound Care in Canada Enabled Through CAN Health, Sunnybrook and MolecuLight Collaboration
—PRESS RELEASEMolecuLight Announces Integration of its i:X® Fluorescence Imaging Device with Net Health’s Tissue Analytics API Program
—PRESS RELEASEMolecuLight Receives Innovative Technology Contract from Vizient for its i:X® Fluorescence Wound Imaging Device
—PRESS RELEASEMolecuLight Announces the Appointment of 11 Global Distributors
—PRESS RELEASEMolecuLight i:X® Platform Available to 650 Long-Term Healthcare Facilities Through Synergy HealthCare Alliance, LLC
—PRESS RELEASEResults Published in Study Show MolecuLight Fluorescence Point-of-Care Imaging Detected Pseudomonas Aeruginosa (PA) in Wounds with a PPV of 93%
2020
—PRESS RELEASE
Wound Care Plus, LLC Adopts the MolecuLight i:X® as a Standard Point-of-Care Device for its Wound Care Service Offering to the Long-Term Care and Extended Care Markets
—PRESS RELEASEResults Published from 2-Year Study of 229 Wounds Treated in an NHS Clinic Show Fluorescence Point-of-Care Imaging Improved Wound Healing Rates by 23%
—PRESS RELEASEResults from 350-Patient FLAAG Trial Show MolecuLight Point-of-Care Imaging Improves Detection of High Bacterial Burden in Wounds Four-fold over Standard of Care Assessment
—PRESS RELEASEMolecuLight Announces Availability of its MolecuLight i:X® Platform on Epic’s App Orchard
—PRESS RELEASEMolecuLight Launches i:X® Sterile Surgical Sleeve for Imaging of Bacteria in Wounds in a Surgical Setting
—PRESS RELEASEMolecuLight i:X® Platform Available to 9,000 Healthcare Facilities Through MAGNET GROUP GPO
—PRESS RELEASEMolecuLight Announces CMS has Assigned an APC Reimbursement Code for its MolecuLight i:X® Procedure for Bacterial Imaging using Fluorescence
—PRESS RELEASEMolecuLight Announces Industry Partnership and Virtual Exhibit of its MolecuLight i:X® Platform at WoundCon™ 2020, the Largest Conference for Wound Care
—PRESS RELEASEFirst Published Study to Report In Vitro Detection of Fluorescence from Bacteria in Biofilm with Point-of-care Wound Imaging Device
—PRESS RELEASENew MolecuLight i:X® Upgrade Enables Faster, More Accurate Digital Wound Measurement
—PRESS RELEASEAmerican Medical Association Issues Category lll CPT Code for Real-time Fluorescence Wound Imaging
—PRESS RELEASEUniversity Hospitals Ahuja Medical Center Physician First in Ohio to Use Wound Care Imaging Device in Clinical Setting
2019
—PRESS RELEASE
MolecuLight Receives FDA 510(k) Clearance for its i:X® Handheld Fluorescence Imaging Device for Wound Management
—PRESS RELEASEAMA Announces Approval for Category lll CPT Code for Real-time Fluorescence Wound Imaging
—PRESS RELEASEClinical Results from the MolecuLight i:X® Fluorescence Imaging System are Featured in Two Clinical Talks and Seven Posters at the SAWC Fall 2019 Annual Conference
—PRESS RELEASEResults from Clinical Studies using MolecuLight i:X® Fluorescence Imaging System Featured Prominently at the Wounds Canada 2019 Annual Conference
—PRESS RELEASEPublished Study Finds 9/10 Chronic Wound Patients Likely to Have Received More Appropriately Triaged Care with Information from the MolecuLight i:X® Imaging Device
—PRESS RELEASEOxford Finance LLC Provides $7.5M USD Term Loan to MolecuLight® Inc. to Support Global Commercial Expansion
—PRESS RELEASEphotonamic GmbH & Co. KG (Germany) Acquires the Oncology Business from MolecuLight® Inc. (Canada)
2018
—PRESS RELEASE
MolecuLight® Inc.’s first-of-its-kind handheld fluorescence imaging device receives FDA De Novo clearance for US wound care market
—NEWSMolecuLight® partners with SerenaGroup for a multi-center clinical trial
—NEWSMolecuLight clinical insights from EWMA 2018
—NEWSNew Publication: Efficacy of an imaging device at identifying the presence of bacteria in wounds at a plastic surgery outpatients clinic
2017
—BLOG
The role of the MolecuLight i:X in potential improvement of current debridement practices
—PRESS RELEASEMolecuLight announces appointment of Anil Amlani as CEO
—BLOGPredicting the presence of pathogenic bacteria in wounds
—BLOGFish skin for human wounds: Iceland’s pioneering treatment
—NEWSNew Publication: Predicting the presence of pathogenic bacteria in wounds
—NEWSRose Raizman receives EWMA e-poster prize
—NEWSImproving antimicrobial stewardship practices with the MolecuLight i:X
—NEWSHow will fluorescence imaging impact wound care?
—NEWSEWMA 2017 update
—NEWSThe use of MolecuLight i:X in managing burns
—NEWSMolecuLight at SAWC Spring 2017
—NEWSMolecuLight i:X featured in the Toronto Star.
—NEWSMolecuLight i:X performs better than Levine method to maximize sampling of treatment-relevant pathogens in chronic wounds.
—BLOGWill the ‘urgent need’ for new drugs be sufficient in the fight against bacteria?
—NEWSThe MolecuLight i:X a novel solution in the ever-increasing battle against antibiotic resistance?
—BLOGAntibiotic resistance continues to be a real issue
2016
—BLOG
